Abstract 14903: Evaluation of the Effectiveness of Warfarin Anticoagulation in Welsh Patients With Non-Valvular Atrial Fibrillation: The Sail Warfarin Out of Range Descriptors Study (SWORDS)

Daniel E. Harris,Daniel Thayer,Caroline J. Brooks,Gravenor Michael,Nathan R. Hill,Geoff Murley,Francisca Vargas Lopes,Ting Wang,S. Lister,Julian Halcox

Abstract 14903: Evaluation of the Effectiveness of Warfarin Anticoagulation in Welsh Patients With Non-Valvular Atrial Fibrillation: The Sail Warfarin Out of Range Descriptors Study (SWORDS)

2018

Daniel E. Harris
Daniel Thayer
Caroline J. Brooks
Gravenor Michael
Nathan R. Hill
Geoff Murley
Francisca Vargas Lopes
Ting Wang
S. Lister
Julian Halcox

Introduction: The target International Normalised Range (INR) for patients with non-valvular atrial fibrillation (NVAF) prescribed vitamin K antagonist (VKA) therapy is 2-3. The net clinical benefi...

Keywords:

Vitamin K antagonist
Atrial fibrillation
Medicine
Vitamin K Inhibitors
non valvular atrial fibrillation
Warfarin
Cardiology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations